BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16149221)

  • 1. [The molecular screening of the stool for the colorectal carcinoma].
    Voboril R; Weberová J; Dvorák J
    Rozhl Chir; 2005 Jun; 84(6):281-5. PubMed ID: 16149221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia.
    Tagore KS; Lawson MJ; Yucaitis JA; Gage R; Orr T; Shuber AP; Ross ME
    Clin Colorectal Cancer; 2003 May; 3(1):47-53. PubMed ID: 12777192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colorectal exfoliated cell in stool and its nuclear DNA quantitative analysis for diagnosis of colorectal cancer].
    Fan RY; Li SR; Wu ZT; Wu X; Chen ZM
    Ai Zheng; 2002 Jul; 21(7):776-80. PubMed ID: 12479106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stool-based DNA tests for colorectal cancer: clinical potential and early results.
    Ahlquist DA
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S20-6. PubMed ID: 12439395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular stool screening for colorectal cancer.
    Mak T; Lalloo F; Evans DG; Hill J
    Br J Surg; 2004 Jul; 91(7):790-800. PubMed ID: 15227685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.
    Zou H; Taylor WR; Harrington JJ; Hussain FT; Cao X; Loprinzi CL; Levine TR; Rex DK; Ahnen D; Knigge KL; Lance P; Jiang X; Smith DI; Ahlquist DA
    Gastroenterology; 2009 Feb; 136(2):459-70. PubMed ID: 19026650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal multiple molecular tests to detect colorectal cancer in stool.
    Calistri D; Rengucci C; Bocchini R; Saragoni L; Zoli W; Amadori D
    Clin Gastroenterol Hepatol; 2003 Sep; 1(5):377-83. PubMed ID: 15017656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
    Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
    Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
    Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces.
    Onouchi S; Matsushita H; Moriya Y; Akasu T; Fujita S; Yamamoto S; Hasegawa H; Kitagawa Y; Matsumura Y
    Anticancer Res; 2008; 28(1A):145-50. PubMed ID: 18383838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of stool DNA mutations before and after treatment of colorectal neoplasia.
    Syngal S; Stoffel E; Chung D; Willett C; Schoetz D; Schroy P; Jagadeesh D; Morel K; Ross M
    Cancer; 2006 Jan; 106(2):277-83. PubMed ID: 16342248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.
    Loktionov A; O'Neill IK; Silvester KR; Cummings JH; Middleton SJ; Miller R
    Clin Cancer Res; 1998 Feb; 4(2):337-42. PubMed ID: 9516920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis.
    Matsushita H; Matsumura Y; Moriya Y; Akasu T; Fujita S; Yamamoto S; Onouchi S; Saito N; Sugito M; Ito M; Kozu T; Minowa T; Nomura S; Tsunoda H; Kakizoe T
    Gastroenterology; 2005 Dec; 129(6):1918-27. PubMed ID: 16344060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers for colorectal cancer screening.
    Dickinson BT; Kisiel J; Ahlquist DA; Grady WM
    Gut; 2015 Sep; 64(9):1485-94. PubMed ID: 25994221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer.
    Spethmann S; Fischer C; Wagener C; Streichert T; Tschentscher P
    Int J Mol Med; 2004 Mar; 13(3):451-4. PubMed ID: 14767578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Target Stool DNA Test: Is the Future Here?
    Sweetser S; Ahlquist DA
    Curr Gastroenterol Rep; 2016 Jun; 18(6):30. PubMed ID: 27165404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
    Berger BM; Ahlquist DA
    Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stool test for colorectal cancer screening: what is going on?
    Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
    Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed.
    Ahlquist DA
    BMJ; 2000 Jul; 321(7256):254-5. PubMed ID: 10915110
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of the mutated K-Ras biomarker in colorectal carcinoma.
    Doolittle BR; Emanuel J; Tuttle C; Costa J
    Exp Mol Pathol; 2001 Jun; 70(3):289-301. PubMed ID: 11418008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.